Upload
colalife
View
265
Download
0
Embed Size (px)
Citation preview
Global Public Health Team, Janssen, Beerse, Belgium ColaLife learning and opportunities in emerging markets
Simon Berry
ColaLife is a charity registered in the UKCharity number: 1142516
• Small, independent and catalytic• Focus on saving children’s lives• Looking for global impact through
• Innovation• Generating robust evidence• Sharing findings and learning• Influencing healthcare strategies
• No commercial interest
2009
2010
2011
2012
2013
1985What is ColaLife and who am I?
Our starting point
Global Public Health Team, Janssen, Beerse, Belgium ColaLife learning and opportunities in emerging markets
26-Aug-15
What we did What we learnt
2 3
How we can support
5
1
Nuggets
4
Our starting point
Global Public Health Team, Janssen, Beerse, Belgium ColaLife learning and opportunities in emerging markets
26-Aug-15
What we did What we learnt
How we can support
2 3
5
1
Nuggets
4
Coca-Cola gets to most places, life-saving medicines don’t
Under 5 mortality is unacceptably high…
…when compared with more developed countries
Diarrhoea is the second biggest killer
Diarrhoea
Sep 2010 | Enrolled into the J&J Innovation Bootcamp
Kris Pintens
Michelle Akande
Johan Offermans
Jane Berry
Alexander Bielders Simon Berry
Some of the ColaLife funders
Isenberg Family Charitable Foundation
Awards | The Kit Yamoyo has won many global awards
Our starting point
Global Public Health Team, Janssen, Beerse, Belgium ColaLife learning and opportunities in emerging markets
26-Aug-15
What we did What we learnt
How we can support
2 3
5
1
Nuggets
4
impact Mothers in underserved rural communities increase use of ORS and Zinc in home treatment of diarrhoea
purposeTarget communities in two under-served rural districts have improved access to ORS and Zinc
outputsProfit-driven supply chains improve availability of ADKs (anti-diarrhoea kits) in targeted communities in two underserved rural districts
Mothers/care-givers demonstrate awareness of ADKs and the benefits of the contents (ORS, Zinc and Soap)
access = ADK in the hand of an aware mother/care-giver
Availability = ADK in stock in retail outlets at community level
Generating robust evidence - the COTZ results framework
Dec 2011
The trial timeline
Mimicking Coca-Cola – creating a product people WANT
What we learnt
Litre sachets are too big
Measuring water was an issue
Willingness to pay
Preferred branding
Kit Yamoyo
Kit Yamoyo• Attractive• Affordable• Packaging is also:
• A measuring device for the water
• A mixing device• A storage device (the
soap tray is a lid)• A cup• And can be re-used
Mimicking Coca-Cola – Community-based marketing
Our starting point
Global Public Health Team, Janssen, Beerse, Belgium ColaLife learning and opportunities in emerging markets
26-Aug-15
What we did What we learnt
How we can support
2 3
5
1
Nuggets
4
0Nobody sold ORS or Zinc in the private sector.
Stock-outs in the public sector were common.
0Nobody sold ORS or Zinc in the private sector.
Stock-outs in the public sector were common.
<1%of children received the correct treatment for diarrhoea
0Nobody sold ORS or Zinc in the private sector.
Stock-outs in the public sector were common.
<1%of children received the correct treatment for diarrhoea
7.3kmWas the average distance to ORS.
60%Only 60% of mothers mixed ORS correctly when given 1 litre sachets.
0Nobody sold ORS or Zinc in the private sector.
Stock-outs in the public sector were common.
<1%of children received the correct treatment for diarrhoea
7.3kmWas the average distance to ORS.
60%Only 60% of mothers mixed ORS correctly when given 1 litre sachets.
0Nobody sold ORS or Zinc in the private sector.
Stock-outs in the public sector were common.
<1%of children received the correct treatment for diarrhoea
7.3kmWas the average distance to ORS.
60%Only 60% of mothers mixed ORS correctly when given 1 litre sachets.
0Nobody sold ORS or Zinc in the private sector.
Stock-outs in the public sector were common.
<1%of children received the correct treatment for diarrhoea
7.3kmWas the average distance to ORS.
>26kkits sold into the two remote rural trial areas in 12 months.
60%Only 60% of mothers mixed ORS correctly when given 1 litre sachets.
0Nobody sold ORS or Zinc in the private sector.
Stock-outs in the public sector were common.
<1%of children received the correct treatment for diarrhoea
7.3kmWas the average distance to ORS.
>26kkits sold into the two remote rural trial areas in 12 months.
45%of children in trial areas received ORS/Zinc. Up from a baseline of <1%. Comparator sites stayed at <1%.
60%Only 60% of mothers mixed ORS correctly when given 1 litre sachets.
0Nobody sold ORS or Zinc in the private sector.
Stock-outs in the public sector were common.
<1%of children received the correct treatment for diarrhoea
7.3kmWas the average distance to ORS.
>26kkits sold into the two remote rural trial areas in 12 months.
45%of children in trial areas received ORS/Zinc. Up from a baseline of <1%. Comparator sites stayed at <1%.
2.4kmThe distance to ORS/Zinc in the trial areas was reduced by two-thirds from 7.3km to 2.4km.
60%Only 60% of mothers mixed ORS correctly when given 1 litre sachets.
0Nobody sold ORS or Zinc in the private sector.
Stock-outs in the public sector were common.
<1%of children received the correct treatment for diarrhoea
7.3kmWas the average distance to ORS.
>26kkits sold into the two remote rural trial areas in 12 months.
45%of children in trial areas received ORS/Zinc. Up from a baseline of <1%. Comparator sites stayed at <1%.
2.4kmThe distance to ORS/Zinc in the trial areas was reduced by two-thirds from 7.3km to 2.4km.
93%of Kit Yamoyo users mixed ORS correctly. Only 60% do when given 1 litre sachets.
60%Only 60% of mothers mixed ORS correctly when given 1 litre sachets.
0Nobody sold ORS or Zinc in the private sector.
Stock-outs in the public sector were common.
<1%of children received the correct treatment for diarrhoea
7.3kmWas the average distance to ORS.
>26kkits sold into the two remote rural trial areas in 12 months.
45%of children in trial areas received ORS/Zinc. Up from a baseline of <1%. Comparator sites stayed at <1%.
2.4kmThe distance to ORS/Zinc in the trial areas was reduced by two-thirds from 7.3km to 2.4km.
93%of Kit Yamoyo users mixed ORS correctly. Only 60% do when given 1 litre sachets.
Manufacture
Assembly
Distribution
WholesaleK3.10
RetailK3.70
CustomerK5.00
Value
Kit Yamoyos
Demand PULLED the Kit Yamoyo into rural communities
What we learned (1)
1. Value chain• Affordable• Profitable for all• Perceived value• Delivers to expectations (use of standards)• Product design• Attractive• Aspirational
2. Sensible use of subsidy• Top-end subsidy (non-corruption of the value chain)• Use of vouchers
What we learned (2)
3. Behavior change works better with a product4. Organisations already exist but may need:• Bringing together in new ways• Capacity building
5. Partnership and shared risk• Donor support for trials and start-up• Donor support for awareness raising and training• Private sector for sustainable production
6. Think about multi-channels to market• Are the private sector needs different from the public sector
needs?
We continue to learn – use of tablets in the scale-up
We continue to learn – use of tablets in the scale-up
Our starting point
Global Public Health Team, Janssen, Beerse, Belgium ColaLife learning and opportunities in emerging markets
26-Aug-15
Nuggets
What we did What we learnt
How we can support
2 3
5
1
4
Network diagram – the trial
http://www.colalife.org/2013/11/05/the-cotz-network-diagram/
Network diagram – the scale-up
Network diagram – sustainability
Voucher system – scale-up version
Voucher system – mark 2
Voucher system – scale-up version
Voucher system – scale-up version
Voucher system – scale-up version
Voucher system – scale-up version
Voucher system – scale-up version
Voucher system – scale-up version
Voucher system – scale-up version
Insights for Janssen? - A wider view of Access?
Access considerations might usefully be expanded:
1. Asking the customer• Review products destined for African market• Find out what people WANT not on what you think they NEED
2. Adapting better to the African context• Insights from working more closely with NGOs, local private sector
3. Advocacy with government, regulators, pharmacists4. Deliver Advantage
• All along the value chain – ‘price minus costing’ not ‘cost plus pricing’5. Awareness-raising
• Not just advertising• Invest in customer education, retailer or wholesaler training
6. Aspiration• Produce products that people aspire to use• The poor are as brand and quality aware as anybody else
Our starting point
Global Public Health Team, Janssen, Beerse, Belgium ColaLife learning and opportunities in emerging markets
26-Aug-15
What we did What we learnt
How we can support
2 3
5
1
Nuggets
4
Our partnership – possible next steps
1. It’s about partnership for global impact (not funding)
2. Sharing our learning to impact on the way Janssen does business in Africa (open access with support from ColaLife)
3. Use ColaLife as a catalyst for change• The grain in the oyster / the yeast in the bread
4. For this to work ColaLife would need a point of contact with the Management Board and Global Public Health team
Questions?Comments?